Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1974 Feb;53(2):554–558. doi: 10.1172/JCI107589

Hereditary deficiency of the sixth component of complement in man. II. Studies of hemostasis.

R S Heusinkveld 1, J P Leddy 1, M R Klemperer 1, R T Breckenridge 1
PMCID: PMC301498  PMID: 11344569

Abstract

Prompted by previous observations of defective blood clotting in rabbits deficient in the sixth component of complement (C6), an evaluation was made of the hemostatic functions of the homozygous proband of a newly recognized human kindred with hereditary C6 deficiency. This human subject, who had no clinical evidence of a bleeding disorder, exhibited a total lack of C6 by functional and immunoprecipitin assays of serum or plasma. Standard tests of hemostatic function were normal; however, when the whole blood clotting time was measured at 25 degrees C in plastic tubes, it was at the upper range of our normal values. In confirmation of this observation, prothrombin consumption, when performed at 37 degrees C in plastic tubes, was at the lower range of normal. Inulin and endotoxin, in concentrations shown to cause activation of human complement, had little or no effect on clotting times or prothrombin consumption of normal or C6-deficient human blood. These observations indicate that absence of C6 does not have a significant effect on hemostatic function in man. In the light of other investigations, the observed differences in clotting function between C6-deficient human blood and C6-deficient rabbit blood could be due to species differences governing the susceptibility of platelets to complement activation.

Full text

PDF
554

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BRECKENRIDGE R. T., RATNOFF C. D. Studies on the nature of the circulating anticoagulant directed against antihemophilic factor: with notes on an assay for anthemophilic factor. Blood. 1962 Aug;20:137–149. [PubMed] [Google Scholar]
  2. Bell D. A., Leblond P. F., Leddy J. P., Lauf P. K., LaCelle P. L., Weed R. I. Immune hemolysis. I. Differing susceptibility of three genetic types of sheep red cells. J Immunol. 1972 Feb;108(2):467–474. [PubMed] [Google Scholar]
  3. Bleyer W. A., Breckenridge R. T. Studies on the detection of adverse drug reactions in the newborn. II. The effects of prenatal aspirin on newborn hemostasis. JAMA. 1970 Sep 21;213(12):2049–2053. [PubMed] [Google Scholar]
  4. Donaldson V. H. Blood coagulation and related plasma enzymes in inflammation. Ser Haematol. 1970;3(1):39–95. [PubMed] [Google Scholar]
  5. HOROWITZ H. I., DES PREZ R. M., HOOK E. W. Effects of bacterial endotoxin on rabbit platelets. II. Enhancement of platelet factor 3 activity in vitro and in vivo. J Exp Med. 1962 Nov 1;116:619–633. doi: 10.1084/jem.116.5.619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. INGRAM I. C. The determination of plasma fibrinogen by the clot-weight method. Biochem J. 1952 Aug;51(5):583–585. doi: 10.1042/bj0510583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. LANGDELL R. D., WAGNER R. H., BRINKHOUS K. M. Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure. J Lab Clin Med. 1953 Apr;41(4):637–647. [PubMed] [Google Scholar]
  8. LOSOWSKY M. S., HALL R., GOLDIE W. CONGENITAL DEFICIENCY OF FIBRIN-STABILISING FACTOR; A REPORT OF THREE UNRELATED CASES. Lancet. 1965 Jul 24;2(7404):156–158. doi: 10.1016/s0140-6736(65)90233-3. [DOI] [PubMed] [Google Scholar]
  9. Leddy J. P., Frank M. M., Gaither T., Baum J., Klemperer M. R. Hereditary deficiency of the sixth component of complement in man. I. Immunochemical, biologic, and family studies. J Clin Invest. 1974 Feb;53(2):544–553. doi: 10.1172/JCI107588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. McKAY D. G., SHAPIRO S. S., SHANBERGE J. N. Alterations in the blood coagulation system induced by bacterial endotoxins. II. In vitro. J Exp Med. 1958 Mar 1;107(3):369–376. doi: 10.1084/jem.107.3.369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mueller-Eckhardt C., Lüscher E. F. Immune reactions of human blood platelets. IV. Investigations on the problem of an immunologically induced effect of endotoxin on human platelets. Thromb Diath Haemorrh. 1968 Dec 31;20(3):336–344. [PubMed] [Google Scholar]
  12. Packham M. A., Mustard J. F. Platelet reactions. Semin Hematol. 1971 Jan;8(1):30–64. [PubMed] [Google Scholar]
  13. QUICK A. J., FAVRE-GILLY J. E. The prothrombin consumption test; its clinical and theoretic implications. Blood. 1949 Dec;4(12):1281–1289. [PubMed] [Google Scholar]
  14. RATNOFF O. D., DAVIE E. W., MALLETT D. L. Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent. J Clin Invest. 1961 May;40:803–819. doi: 10.1172/JCI104314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. ROBBINS J., STETSON C. A., Jr An effect of antigen-antibody interaction on blood coagulation. J Exp Med. 1959 Jan 1;109(1):1–8. doi: 10.1084/jem.109.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ratnoff O. D. Some relationships among hemostasis, fibrinolytic phenomena, immunity, and the inflammatory response. Adv Immunol. 1969;10:145–227. doi: 10.1016/s0065-2776(08)60417-4. [DOI] [PubMed] [Google Scholar]
  17. SPAET T. H., CINTRON J. STUDIES ON PLATELET FACTOR-3 AVAILABILITY. Br J Haematol. 1965 May;11:269–275. doi: 10.1111/j.1365-2141.1965.tb06587.x. [DOI] [PubMed] [Google Scholar]
  18. Siraganian R. P. Platelet requirement in the interaction of the complement and clotting systems. Nat New Biol. 1972 Oct 18;239(94):208–210. doi: 10.1038/newbio239208a0. [DOI] [PubMed] [Google Scholar]
  19. Zimmerman T. S., Arroyove C. M., Müller-Eberhard H. J. A blood coagulation abnormality in rabbits deficient in the sixth component of complement (C6) and its correction by purified C6. J Exp Med. 1971 Dec 1;134(6):1591–1600. doi: 10.1084/jem.134.6.1591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Zimmerman T. S., Müller-Eberhard H. J. Blood coagulation initiation by a complement-mediated pathway. J Exp Med. 1971 Dec 1;134(6):1601–1607. doi: 10.1084/jem.134.6.1601. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES